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39-cyclic phosphorylation of U6 snRNA leads
to recruitment of recycling factor p110
through LSm proteins
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ABSTRACT
Pre-mRNA splicing proceeds through assembly of the spliceosome complex, catalysis, and recycling. During each cycle the U4/
U6.U5 tri-snRNP is disrupted and U4/U6 snRNA base-pairing unwound, releasing separate post-spliceosomal U4, U5, and U6
snRNPs, which have to be recycled to the splicing-competent tri-snRNP. Previous work implicated p110—the human ortholog
of the yeast Prp24 protein—and the LSm2-8 proteins of the U6 snRNP in U4/U6 recycling. Here we show in vitro that these
proteins bind synergistically to U6 snRNA: Both purified and recombinant LSm2-8 proteins are able to recruit p110 protein to
U6 snRNA via interaction with the highly conserved C-terminal region of p110. Furthermore, the presence of a 29,39-cyclic
phosphate enhances the affinity of U6 snRNA for the LSm2-8 proteins and inversely reduces La protein binding, suggesting a
direct role of the 39-terminal phosphorylation in RNP remodeling during U6 biogenesis.
Keywords: splicing; snRNP recycling; U6 snRNA; Sm-like proteins; La antigen
INTRODUCTION
The removal of introns from eukaryotic pre-mRNAs is
catalyzed by a large macromolecular complex, the spliceo-
some, which consists of more than 100 different proteins
and five small nuclear RNAs (snRNAs). It assembles on
the pre-mRNA in a highly ordered and stepwise process,
involving the U1, U2, and the U4/U6.U5 snRNPs as well as
many non-snRNP protein factors. Prior to the first catalytic
step of the splicing reaction, dynamic structural rearrange-
ments occur that lead to the formation of the active site of
this macromolecular enzyme. This includes the destabili-
zation and early release of the U1 and U4 snRNPs from
the activated spliceosome. During this initial step of the
splicing reaction the U4 and U6 snRNAs that are exten-
sively base-paired to each other in the U4/U6.U5 tri-snRNP
are unwound by the RNA helicase Brr2/U5-200K. This
enables the U6 snRNA to participate in a mutually ex-
clusive RNA base-pairing interaction with the U2 snRNA
and the pre-mRNA in the catalytic core of the spliceosome.
After completion of both steps of the splicing reaction, the
machinery is dismantled, releasing mRNA and intron-lariat
products as well as the U2, U5, and U6 snRNPs as single
entities (for review, see Brow 2002).
For participating in further rounds of splicing the
postspliceosomal single U4, U5, and U6 snRNPs have to
be recycled to the U4/U6.U5 tri-snRNP. First, the U4/U6 di-
snRNP with base-paired U4 and U6 snRNAs reforms, which
subsequently associates with the U5 snRNP via protein–
protein interactions yielding the splicing-competent U4/U6.
U5 tri-snRNP. We have recently identified and character-
ized the human protein p110, which is closely related to
the yeast Prp24 protein (Shannon and Guthrie 1991); p110
binds specifically to an internal U6 sequence, remains only
transiently associated with U6 snRNA, and plays a major
role in recycling the U4/U6 di-snRNP, a prerequisite for
generation of the splicing-competent U4/U6.U5 tri-snRNP
(Raghunathan and Guthrie 1998; Bell et al. 2002; Damianov
et al. 2004). p110 escorts U6 to the Cajal bodies, where
U4/U6 snRNP recycling takes place (Stanek et al. 2003).
The p110-mediated interaction of the U4 and U6
snRNAs is most likely also involved in the de novo
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assembly of the U4/U6 snRNP. The biogenesis of the
spliceosomal U6 snRNP differs in many ways from the
biogenesis of the other spliceosomal snRNPs. In contrast to
U1, U2, U4, and U5 snRNAs that are RNA polymerase II
transcripts and have a cytoplasmic maturation phase, U6
snRNA is transcribed by RNA polymerase III, receives a g-
monomethyl cap (Shimba and Reddy 1994), and probably
never leaves the nucleus (Will and Lu¨hrmann 2001 and
references therein). Furthermore, U6 snRNA contains a
39-oligouridine stretch, the typical RNA polymerase III
termination signal, that is initially bound by the La pro-
tein, an RNA chaperone and stability factor. Subsequently
29-O-methyl ribose and pseudouridine modifications are
introduced into U6 snRNA by guide modification RNPs,
the snoRNPs (Tycowski et al. 1998; Tycowski et al. 2004),
a process taking place in the nucleoli, where U6 snRNA
transiently travels through (Lange and Gerbi 2000).
Surprisingly this 39-terminal uridine stretch of U6 is not
static, but noncoded residues are post-transcriptionally
incorporated into U6 snRNA by a U6-specific terminal
uridyl transferase (TUTase; Trippe et al. 1998, 2006), and
therefore U6 variants with up to 12 uridines are found that
can assemble into di- and tri-snRNPs (Lund and Dahlberg
1992; Tazi et al. 1993). The majority of mature U6 snRNA
carries a 29,39-cyclic phosphate end (Lund and Dahlberg
1992), and is associated with a set of seven LSm proteins,
LSm2-8, instead of the La protein (Se´raphin 1995; Achsel
et al. 1999; Mayes et al. 1999; Salgado-Garrido et al. 1999;
Vidal et al. 1999; for review, see Khusial et al. 2005). The
LSm2-8 proteins are organized in form of a heterohepta-
meric ring structure, analogously to the classical Sm ring,
and LSm binding requires the 39-terminal uridine stretch,
the same region where La is initially bound. Therefore, it is
assumed that after formation of the 29,39-cyclic phosphate
at the 39 end of U6 snRNA, the La protein dissociates from
U6 snRNA. Once the LSm2-8 complex is bound, it keeps
U6 in the nucleus (Spiller et al. 2007).
Interestingly, LSm2-8 proteins purified from HeLa
nuclear extract interact with U6 snRNA in vitro and
promote U4-U6 snRNA annealing without any additional
factors (Achsel et al. 1999). Moreover, a direct interaction
between the LSm2-8 proteins and the Prp24 recycling
factor was demonstrated in S. cerevisiae; deletion of the
highly conserved C-terminal sequence motif in Prp24
abolished the interaction with LSm2-8 in yeast-two-hybrid
assays; it also resulted in a cold-sensitive growth phenotype,
due to inefficient U4/U6 snRNP recycling based on reduced
association of Prp24 with the U6 snRNP (Rader and
Guthrie 2002). Furthermore, extracts prepared from yeast
strains lacking functional LSm6 or -7 proteins—although
viable—were unable to maintain splicing activity over
several sequential incubations either due to a reduced
stability of the U4/U6 di-snRNP and U4/U6.U5 tri-snRNP
or—more likely—a defect in U4/U6 recycling (Verdone
et al. 2004). Finally, the LSm site of U6 snRNA becomes
accessible for crosslinking during splicing, and thus the
LSm proteins appear to dissociate during activation of the
spliceosome (Chan et al. 2003; Bessonov et al. 2008). Taken
together, these data imply a direct role for LSm proteins in
U4/U6 snRNP recycling with an association/dissociation
cycle similar to what we have proposed for the function of
p110 (Bell et al. 2002).
Here we report that LSm2-8 and p110 proteins bind
synergistically to U6 snRNA. This effect depends both on
the presence of the C-terminal, highly conserved region of
p110 and an intact LSm2-8 binding site in U6 snRNA.
Furthermore, compared to a 39-hydroxyl, the presence of a
U6 29,39-cyclic phosphate end enhances the affinity to re-
combinant LSm2-8 proteins. Inversely, the interaction with
recombinant La protein is impaired by the 29,39-cyclic
phosphate end, implying a direct role of 39-terminal modi-
fication in RNP remodeling during U6 snRNP biogenesis.
RESULTS
39-terminal modifications of U6 snRNA modulate
binding of LSm2-8 and La proteins
Mature U6 snRNA carries an unusual 39 terminus with a
29,39-cyclic phosphate (>P), in contrast to newly synthe-
sized U6 snRNA with a uridine stretch of variable length
and a 39-hydroxyl end (Lund and Dahlberg 1992). There-
fore we compared binding of the LSm2-8 complex to U6
snRNAs with a 39-hydroxyl or a 29,39-cyclic phosphate end
(Fig. 1C,D; see Fig. 1A for a protein analysis). U6 snRNA
was in vitro transcribed, either by DraI runoff transcription
(U6-39OH) or by Hepatitis delta virus (HDV) ribozyme-
mediated endonucleolytic cleavage (U6>P), followed by
gel purification. As expected, U6 snRNA with a 29,39-cyclic
phosphate end had a slightly faster gel mobility; poly-
nucleotide kinase treatment converted the 29,39-cyclic
phosphate end to 29- and 39-hydroxyl termini (Fig. 1C, cf.
lanes 1–3; Cameron and Uhlenbeck 1977).
32P-labeled U6 snRNA with either the 39-hydroxyl or the
29,39-cyclic phosphate end were incubated with recombi-
nant LSm2-8 protein complex in different molar ratios.
Complex formation was followed by native gel electropho-
resis, and binding affinities were determined by quantita-
tion. We found that U6 snRNA with the cyclic phosphate
exhibited an approximately twofold higher affinity for
LSm2-8 proteins compared to U6 snRNA with the 39-
hydroxyl [U6-39OH: KD 518 6 30 nM, n = 3; U6>P(5U):
KD 274 6 34 nM, n = 5] (see Fig. 1D). To rule out that 39-
non-templated nucleotides and 39-end heterogeneity in the
runoff transcripts (Milligan et al. 1987) are responsible for
this effect, we converted the 29,39-cyclic phosphate to a 29-
or 39-hydroxyl group using polynucleotide kinase, resulting
in decreased binding affinity (data not shown). This shows
clearly that the observed effect is indeed due to the presence
or absence of the cyclic phosphate at the 39 end of U6 snRNA.
Recycling factor p110 and LSm proteins
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The U6 snRNA is also heterogeneous in the length of
its 39-terminal uridine stretch (Lund and Dahlberg 1992).
Longer forms, with up to 12 uridines, are thought to be
precursors to the shorter forms and U6 with a 29,39-cyclic
phosphate end. Therefore we compared
the LSm2-8 affinity to U6 snRNA with
five uridines (as found in the majority of
U6 snRNA) or 12 uridines, either one
with a 29,39-cyclic phosphate end. Band-
shift assays revealed that the affinity to
LSm2-8 was significantly higher for the
39-extended uridine tails [U6>P(12U):
KD 1506 10 nM, n= 3, versusU6>P(5U):
KD 274 6 34 nM, n = 5] (see Fig. 1E).
In sum, we have shown that 39-
terminal modifications (both the 39
terminus itself and the length of the
39-uridine stretch) can modulate the
LSm2-8 binding affinity.
In addition to the LSm2-8 proteins,
the La protein is involved in the early
stages of U6 snRNP biogenesis. There-
fore we tested next how 39-terminal
modifications (29,39-cyclic phosphate
versus 39-hydroxyl end) and LSm2-8
binding affect La association (Fig. 2). As
followed by native gel electrophoresis,
La bound specifically to U6 snRNA
with a 39-hydroxyl end, but not to U6
with a cyclic phosphate 39 end (Fig. 2,
lanes 2,7). The LSm2-8 complex bound
both forms, but U6 snRNA with a cyclic
phosphate 39 end with a higher affinity
(Fig. 2, lanes 3,8, compare with Fig. 1).
In contrast, the LSm1-7 complex showed
only background binding activity to
both U6 snRNA forms (Fig. 2, lanes
4,9). The strong selectivity of LSm2-8
versus La binding was underlined, when
either of the two U6 snRNA forms was
incubated first with the LSm2-8 com-
plex, then with La protein: La was able
to completely displace the LSm2-8 com-
plex from U6-39OH; this depended on
the 39OH end, since with U6>P the same
sequential binding resulted in the exclu-
sive formation of the U6/LSm2-8 com-
plex (Fig. 2, lanes 5,10).
LSm2-8 and p110 proteins bind
synergistically to U6 snRNA,
depending on the p110 C terminus
and the LSm binding site
of U6 snRNA
Since our previous work has shown that p110 binds
specifically to U6 snRNA (Bell et al. 2002), we next
determined whether binding of both p110 and LSm
proteins can be detected by native gel electrophoresis and
FIGURE 1. 39-terminal modifications of the U6 snRNA modulate LSm2-8 binding. Analysis of
recombinant proteins and of purified human LSm2-8 complex. (A) Recombinant LSm1-7 (lane
1) and LSm2-8 (lane 2) complexes, as well as subcomponents LSm1, 2/3, 4, 4/8, and 5/6/7
(lanes 3–7) (Zaric et al. 2005), were analyzed by SDS-PAGE and detected by Coomassie blue
staining (identities on the right). M, molecular weight markers (in kDa). (B) Bacterially
expressed GST-tagged La protein (GST-La [lane 1]), and baculovirus-expressed His-tagged
p110 (His-p110 [lane 2]) and p110 lacking the 10 C-terminal amino acids (His-p110 DC10
[lane 3]). The proteins were analyzed as in A. (C) In vitro transcribed, 32P labeled U6 snRNAs
with different 39 ends were analyzed by denaturing gel electrophoresis (lane 1, 39-hydroxyl end
(U6-39OH); lane 2, 29,39-cyclic phosphate end (U6>P); lane 3, 29,39-cyclic phosphate end after
polynucleotide kinase treatment (U6>P/PNK). Below, the secondary structure model of human
U6 snRNA with the 39-terminal HDV domain (in gray), which is autocatalytically cleaved
(arrow), generating U6 snRNA with a 29,39-cyclic phosphate end. Marker positions are
indicated on the left (in nucleotides). (D,E) In vitro transcribed, 32P labeled U6 snRNAs
U6-39OH (A, lanes 1–9) or U6>P(5U) (A, lanes 10–18; B, lanes 1–8), or U6>P(12U) (B, lanes
9–16) were incubated with increasing concentrations of recombinant LSm2-8 proteins
(nanomolar concentrations as indicated above the lanes). Complex formation was analyzed
by native gel electrophoresis. The positions of free U6 snRNAs and the U6/LSm2-8 complexes
are marked on the right.
Licht et al.
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how they affect each other (Fig. 3). Recombinant LSm2-8
proteins (and as a control for specificity, recombinant
LSm1-7) were used, as well as recombinant baculoviral-
expressed p110 and a truncated form lacking the highly
conserved C-terminal 10-amino acid sequence (Medenbach
et al. 2004; for a protein analysis, see Fig. 1A,B). We tested
combinations of the individual proteins for their ability
to form stable complexes with in vitro transcribed 32P-
labeled U6 snRNA carrying either a 39-terminal hydroxyl
group (U6-39OH) or the mature 29,39-cyclic phosphate
(U6>P).
The LSm1-7 complex showed no significant binding
activity with U6 snRNA, independently of its 39 end (Fig.
3, lanes 1–4), whereas LSm2-8 very efficiently formed
under the same conditions a U6 snRNP, at higher efficiency
with U6>P than with U6-OH (Fig. 3, cf. lanes 5 and 6),
consistent with our binding experiments described above
(see Fig. 1D). On the other hand, p110 bound both U6
snRNAs at similar, weak efficiency under these conditions
(Fig. 3, lanes 7,8). However, the addition of p110 and the
LSm2-8 complex resulted in efficient formation of a ternary
complex (U6/p110/LSm2-8), which ran slightly above the
U6/p110 complex (Fig. 3, cf. lanes 8 and 9) and which
formed more quantitatively with U6>P than with U6-OH
(Fig. 3, cf. lanes 9 and 10). Ternary complex assembly
required the C-terminal short conserved region of p110,
since the complete assembly reaction with p110DC10
yielded mostly U6/LSm2-8 complex and only low levels
of the complete U6/LSm2-8/p110 complex (Fig. 3, lanes
11–14). In sum, we conclude that LSm2-8 and p110
proteins bind synergistically to U6 snRNA; in initial
experiments we had used the natural LSm2-8 complex
purified from human U4/U6.U5 tri-snRNPs; this revealed
the same binding behavior and dependence on the intact C
terminus of p110, validating our use of the recombinant, in
vitro assembled LSm2-8 complex (data not shown).
To address the question of whether the LSm-U6 inter-
action affects p110 integration, we next introduced several
mutations in the LSm binding site of U6 snRNA that leave
the normal p110 interaction site intact. For ease of cloning
they all lacked the 59 hairpin of U6 (U6-D59stl), since it is
not essential for p110 nor LSm2-8 binding (p110: Bell et al.
2002; LSm2-8: Achsel et al. 1999): U6-LSm-mut and U6-
39DU5, in which the 39-terminal five uridines were replaced
by adenosines or deleted, respectively. In addition, in the
U6-LSm-mut rest mutant the normal secondary structure
of the 39-terminal region of U6 was restored, by introduc-
ing four compensatory A/U mutations in the 59 part of
the U6 intramolecular stem-loop (Fig. 4, see secondary
structures).
For each 32P-labeled U6 snRNA derivative, bandshift
assays were carried out, titrating in p110 protein in the
absence or presence of the LSm2-8 complex (Fig. 4).
Surprisingly, p110 had a higher affinity for the 59-truncated
version of U6 snRNA, which may reflect folding of part of
the full-length U6 snRNA into a structure that is not active
in p110 binding. However, the LSm effect on p110 binding
was still observed (Fig. 4, cf. U6-WT and U6-D59stl).
Deletion or substitution of the 39-terminal uridine stretch
completely abolished LSm2-8 binding (data not shown).
Titration of the p110 protein revealed that p110 association
with the mutant RNAs that are impaired in LSm binding
could not be enhanced any more by the addition of purified
LSm2-8 complex (panels U6-LSm-mut and U6-39DU5,
respectively). This suggests that it is not a p110/LSm
association in the absence of RNA that increases the affinity
of p110 to U6 snRNA per se; instead, the synergistic effect
FIGURE 3. LSm2-8 proteins promote p110 binding to U6 snRNA,
depending on conserved C-terminal p110 region. The interaction of
recombinant proteins LSm1-7, LSm2-8, p110, p110DC10, and combi-
nations thereof (lanes 3–14) with in vitro transcribed, 32P labeled U6
snRNAs (U6-39OH or U6>P; for inputs, see lanes 1,2) was analyzed
by native gel electrophoresis. The mobilities of free RNAs and the
different complexes are indicated on the right.
FIGURE 2. La protein binds exclusively to U6-39OH, displacing
prebound LSm2-8 proteins. Recombinant La protein (lanes 2,7),
LSm2-8 proteins (lanes 3,8), or LSm1-7 proteins (lanes 4,9) were
incubated with in vitro transcribed U6-39OH or U6>P snRNAs (left
and right panels; for inputs, see lanes 1,6). In addition, LSm2-8
proteins were pre-incubated with U6 snRNA, followed by the addition
of La protein (lanes 5,10). Complex formation was analyzed by native
gel electrophoresis.
Recycling factor p110 and LSm proteins
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of p110 and LSm2-8 proteins appears to require prior LSm
binding to the 39 end of U6 snRNA.
In addition, a mutant U6 snRNA was tested, U6-LSm-
mut rest, in which the LSm binding site was inactivated,
and compensatory mutations were introduced that were
designed to mimic the 39-terminal stem: Again, no signif-
icant synergistic effect was observed, indicating that the
39-terminal uridines are required rather than a secondary
structure unit.
DISCUSSION
U6 snRNA plays a central role in spliceosome catalysis and
is engaged in several dynamic changes (see Introduction for
references). Here we have used an in vitro reconstitution
approach to investigate the contributions of the LSm2-8
protein complex and the p110 recycling factor to U6
snRNP dynamics. Initially we have demonstrated that the
association with the LSm2-8 complex and La protein is
modulated by modifications at the 39-terminus of U6
snRNA: Not only the chemical nature of its 39 end (39-
hydroxyl versus 29,39-cyclic phosphate), but also the length
of its 39-terminal uridines is important.
As the LSm2-8 complex and La bind to the 39 end of U6
snRNA in a mutually exclusive fashion, the cyclic phos-
phorylation of the RNA provides a molecular switch for
the exchange of these protein factors. Thus, 39-end mod-
ification would convert the U6 snRNA from an initial,
La-bound state (U6 39OH) to the mature, LSm-bound state
(U6-29,39-cyclic phosphate), which is found predominantly
in snRNPs. It is known that the La protein binds specifically
to RNAs carrying a 39-hydroxyl group, and the recently
published crystal structure of La showed that the 29 and 39
hydroxyl groups of the terminal uridine are contacted by
D33 of the La domain (Teplova et al. 2006). Therefore one
can envision the 29,39-cyclic phosphate of mature U6
snRNA to sterically interfere with La interaction, explaining
the disruption of the La-U6 interaction after 39-end modi-
fication of U6 snRNA. Enzymatic activities involved may be
the 39-terminal phosphate cyclase, which localizes to the
nucleoplasm and is excluded from nucleoli (Genschik et al.
1997; Gu et al. 1997) and the nucleolar U6-specific terminal
uridylyl transferase (TUTase) (Trippe et al. 1998, 2006).
The exact order of all these differentially localized events is
not clear.
Our data argue for a model whereby LSm2-8 binding to
U6 snRNA rapidly recruits the p110 protein. This is based
on in vitro binding assays, which consistently showed that
p110 binds much more efficiently to the U6-LSm complex
than to naked U6 snRNA (see Fig. 3, cf. lanes 1,8 and 6,10).
Moreover, efficient recruitment of p110 onto a U6/LSm2-8
complex strongly depends on the C-terminal conserved
motif of p110, an effect that we have clearly shown here in
a mammalian in vitro system (Fig. 3), but was previously
based only on two-hybrid assays in yeast (Rader and
Guthrie 2002). Yet the C-terminal truncation of p110
(p110 DC10) still is incorporated in a U6 snRNP, although
at a much lower efficiency; this may explain why we had
FIGURE 4. LSm2-8 enhancement of p110 binding to U6 snRNA depends on an intact LSm binding site. Synergistic LSm2-8/p110 binding to
32P-labeled mutant U6 snRNAs were assayed by bandshift assays, using increasing concentrations of recombinant p110 (2, 4, 8, and 20 nM),
either in the absence or presence of LSm2-8 complex purified from human tri-snRNPs (–/+). Lanes I, input RNA. The identities of free RNAs
and the complexes are given on the right. Below the corresponding autoradiograms, mutations are schematically represented and—except for
the full-length wild-type U6 snRNA (U6-WT)—all have the 59-terminal stem-loop deleted (U6-D59stl), and in addition the LSm site mutated
(U6-LSm-mut), the LSm site mutated and base-pairing restored (U6-LSm-mut rest), or the LSm site deleted (U6-39DU5). Shown is only the
bottom part of the 39 stem-loop), except for the full-length U6 snRNA secondary structure model (left side).
Licht et al.
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previously found the p110 C-terminal sequence motif to
be dispensable for recycling activity in vitro (Medenbach
et al. 2004). This rather surprising substrate specificity of
the p110 protein (binding of the U6-LSm RNP versus U6
snRNA) probably reflects different U6 snRNA structures in
the free and protein-bound forms. This has been charac-
terized in detail only for the yeast U6 snRNP, carrying
both LSm2-8 and Prp24, but not distinguishing between




U6 snRNA mutants were PCR-amplified from pUC19-T7-U6
(Wolff and Bindereif 1993) and cloned into pCR2.1-TOPO vector
(Invitrogen). SP6 promotor sequence, mutations, and restriction
sites for runoff transcription (using DraI or NsiI) were introduced
by the PCR primers. For U4 snRNA an MscI runoff plasmid
template was created in a similar fashion from pUC13-U4c
(Wersig and Bindereif 1990) to generate the correct 39 end of
the RNA after transcription. To create the 29,39-cyclic phosphate
of mature U6 snRNA, the Hepatitis Delta Virus (HDV) ribozyme
sequence was cloned 39 of the U6 snRNA sequence essentially as
described (Mo¨rl et al. 2005). Restriction sites and T7 promotor
were introduced by the PCR primers, and the fragment was
inserted into pUC19, using the EcoRI and BamHI restriction sites.
The construct for the 39-extended U6 snRNA [U6>P(12U)] was
created accordingly. Ribozyme cleavage occurred under transcrip-
tion conditions (see below). To remove the 29,39-cyclic phosphate,
U6>P was incubated with 10 U of T4 polynucleotide kinase (NEB)
for 6 h at 37°C in a buffer containing 70 mM Tris-HCl (pH 7.6),
10 mM MgCl2, and 5 mM dithiothreitol, essentially as described
(Mo¨rl et al. 2005).
SnRNAs and mutant derivatives were generated by in vitro run-
off transcription from linearized plasmid templates, in the case of
32P-labeled RNAs in the presence of [a-32P]UTP or -ATP. Sub-
sequently RNAs were purified by denaturing PAGE and gel elution.
Purification of HeLa LSm2-8 proteins
Endogenous human LSm proteins were purified from HeLa
nuclear extract essentially as described before (Achsel et al.
1999). In brief, total snRNPs were immunopurified using an
H20 monoclonal anti-m3G-antibody column and eluted with m
7-
guanosine followed by fractionation on a preparative linear 10%–
30% (w/w) glycerol gradient in buffer G (20 mM HEPES/KOH at
pH 7.9, 150 mM KCl, 1.5 mM MgCl2, 0.5 mM DTT, and 0.5 mM
PMSF). After concentration of the tri-snRNP fractions by ultra-
centrifugation (265,000g, 10 h, 4°C in 10%–30% glycerol gradi-
ent), tri-snRNP particles were partially disrupted by 700 mM
NaCl and fractionated by yet another round of linear 5%–20%
(w/w) glycerol gradient ultracentrifugation (118,000g, 7 h, 4°C).
Fractions containing LSm, but no Sm proteins were dialyzed
against a buffer containing 20 mM HEPES/KOH pH 7.6, 1.5 mM
MgCl2 and 125 mM NaCl, bound to a MonoS column (0.1 mL)
and eluted by a 2-mL linear salt gradient (100–400 mM NaCl in
20 mM HEPES/KOH at pH 7.6, and 1.5 mM MgCl2).
Recombinant proteins
Recombinant LSm1-7 and 2-8 proteins were obtained from C.
Kambach (Zaric et al. 2005), recombinant p110 protein and the
truncated version DC10 were expressed in baculovirus-infected
insect cells and purified as described (Bell et al. 2002; Medenbach
et al. 2004). For the GST-La construct the cDNA of human La
(kindly obtained from G. Pruijn [Pruijn et al. 1991]) was
amplified by PCR, thereby introducing two restriction sites for
KpnI and NcoI and removing an internal restriction site for KpnI.
The PCR fragment was cloned into pETM-30, which contains
an N-terminal GST domain, using the KpnI and NcoI sites. The
protein was expressed in E. coli BL21 Star (Invitrogen) containing
the Rosetta 2 plasmid (Novagen) and purified via glutathione
Sepharose beads (GE Healthcare).
Complex formation and bandshift assays
p110 and/or LSm proteins (concentrations, see below) were
incubated together with 50 fmol 32P-labeled snRNAs in a 10-ml
reaction for 30 min at 30°C or at room temperature in a buffer
containing 12 mM HEPES/KOH pH 7.6, 1.5 mM MgCl2, 100 mM
NaCl, 10% glycerol, 0.1% Triton X-100, and 1 mg of RNase-free
yeast tRNA (Roche). The following concentrations of recombi-
nant/purified LSm proteins were used: Figure 1, 40 nM of LSm
proteins; Figure 2, 1 mM of LSm proteins and 150 nM of La
protein; Figure 3, 0.5 mM of LSm proteins and 50 nM of p110 or
p110DC10. For titration experiments with recombinant LSm
proteins the concentrations are indicated above the lanes (Fig.
1). In the absence of the LSm proteins, LSm binding buffer con-
taining 20 mM HEPES/KOH pH 7.6, 1.5 mM MgCl2, and 200 mM
NaCl was used to compensate the volume, in the absence of p110
buffer D (Dignam et al. 1983) was used. After the incubation
complexes were separated on a native 6% polyacrylamide gel
(acrylamide:N,N9-methylene bisacrylamide 80:1 in 0.5 3 TBE) for
10 h at 2.5 Volts/cm and 4°C (Fig. 4) or for 3–5 h at 7.6 volts/cm
and 4°C (Figs. 1–3). Complexes were visualized by autoradi-
ography and quantified using an Instant Imager (Packard) or
phosphorimager (Bio-Rad).
For the titration experiments, in which U6 mutant snRNAs
were analyzed (Fig. 4), LSm-U6 complexes were preformed for 15
min under the conditions described above (mock reactions with
buffer D only), then a constant volume of buffer D containing the
indicated amount of recombinant p110 protein was added, and
incubation was continued for 15 min. Complexes were separated
and analyzed as described above.
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